HealthQuill Articles by: HealthQuill
Israel has passed a law to ban the United Nations Relief and Works Agency from operating in the country after it earlier accused its employees of participation in the October 7 attacks — a move which came in for criticism from Western European leaders.
Drugs Health Medical

Israel bans UN relief agency, EU, Western European leaders slam move 

Israel has passed a law to ban the UN relief agency, UNRWA, from operating in the country after it earlier accused its employees

Read More
Researchers have found genomic variants in one-third of people from the West African countries of Ghana and Nigeria that significantly increase the risk of developing kidney diseases.
Drugs Health Medical

One-third of West Africans have gene variants causing kidney disease

Researchers have found genomic variants in one-third of people from the West African countries of Ghana and Nigeria that significantly increase the risk

Read More
Exiting plans to combat climate change “fall miles short” of what’s needed to stop global heating from destroying every economy and wrecking billions of lives and livelihoods across every nation, a UN climate official said.
Climate Health Medical

Global heat to cripple economies, wreck billions of lives: UN official says

Exiting plans to combat climate change “fall miles short” of what’s needed to stop global heating from destroying every economy and wrecking billions

Read More
Imposter syndrome is a psychological phenomenon that affects many high-achieving individuals, often leading them to downplay their accomplishments and attribute their success to luck or external factors.
Drugs Health Medical Opinion

Opinion: Imposter syndrome can lead to anxiety, depression, guilt

By Aparna S October 29, 2024: Imposter syndrome is a psychological phenomenon that affects many high-achieving individuals, often leading them to downplay their

Read More
Novartis AG, a global Switzerland-based pharmaceutical company, has agreed to pay Monte Rosa Therapeutics Inc., $150 million upfront to develop, manufacture and commercialise drug candidates, mainly in immunology.
Drugs Health Pharma

Novartis to pay Monte Rosa $150m upfront for MGD drug candidates

Novartis AG, a global Switzerland-based pharmaceutical company, has agreed to pay Monte Rosa Therapeutics Inc., $150 million upfront to develop, manufacture and commercialise

Read More
AbbVie Inc. will acquire Aliada Therapeutics, a biotechnology company focused on developing drugs to treat diseases of the central nervous system such as Alzheimer’s disease, for $1.4 billion in cash.
Drugs Health Pharma

AbbVie to acquire Aliada for $1.4 billion, bags Alzheimer’s therapy 

AbbVie Inc. will acquire Aliada Therapeutics, a biotechnology company focused on developing drugs to treat diseases of the central nervous system such as

Read More
AstraZeneca Plc’s drug Fasenra got approval from the European Union regulator for treating adult patients with a rare inflammation of blood vessels.
Drugs Health Pharma

AstraZeneca’s drug to treat rare blood vessel disease gets EU nod

AstraZeneca Plc’s drug Fasenra got approval from the European Union regulator for treating adult patients with a rare inflammation of blood vessels.

Read More
The world’s top 50 richest billionaires, with their private jets, yachts and polluting investments, produce more carbon pollution in over an hour than an average person does in their lifetime, a study by Oxfam reports.
Climate Health Medical

‘Luxury jets, yachts emit more carbon an hour than a person’s lifetime’

The world’s top 50 richest billionaires, with their private jets, yachts and polluting investments, produce more carbon pollution in over an hour than

Read More
GSK Plc., will invest $800 million in its manufacturing facility in the US — the largest investment to date in the country — to make sterile liquid vaccines and medicines as demand grows.
Drugs Health Pharma

GSK to invest $800 million in US to double capacity at Marietta facility

GSK Plc., will invest $800 million in its manufacturing facility in the US — the largest investment to date in the country — to

Read More
A clinical-stage US gene-editing company, Precision BioSciences, got approval from the Eastern European country of Moldova to start an in vivo human trial of a therapy to treat chronic hepatitis B.
Drugs Health Pharma

Moldova green lights Precision BioSciences human trial for HBV

A clinical-stage US gene-editing company, Precision BioSciences, got approval from the Eastern European country of Moldova to start an in vivo human trial

Read More